Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nitric oxide (NO)-cGMP pathway is a fundamental cellular signaling cascade involved in diverse physiological processes, including smooth muscle relaxation, neural communication, inhibition of platelet aggregation, and pain modulation. NO, produced by NOS, activates sGC, leading to cGMP production. cGMP then activates downstream effectors like PKG. Dysregulation is implicated in cardiovascular and neurological diseases, making it a target for therapeutic intervention.
Modulation of nitric oxide production, sGC activation, or cGMP degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide-cGMP Pathway (None).